Company Sinew Pharma Inc.

Equities

6634

TW0006634009

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
55.3 ^TWD	-1.25%		-2.47%	-18.32%

19/03	Sinew Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Sinew Pharma Inc.(TPEX:6634) added to S&P Global BMI Index	CI

Sinew Pharma Inc is a Taiwan-based company mainly engaged in the development and research of new drugs. The Company primarily focus on the research and development of liver disease treatment drugs and pain medication. The Company's main products include fatty liver disease treatment drugs SNP-610, SNP-630, no hepatotoxicity painkillers SNP-810 and antidote SNP-820. The Company's products are in clinical trials.

Number of employees: 52

Managers	Title	Age	Since
Kai Min Zhu CEO	Chief Executive Officer	-	18/14/18
Tzu Wen Chen DFI	Director of Finance/CFO	-	-
Cheng Hui Hsiung CTO	Chief Tech/Sci/R&D Officer	-	01/14/01

Members of the board	Title	Age	Since
Chih Chuan Chen BRD	Director/Board Member	-	-
Li Chun Han BRD	Director/Board Member	66	27/19/27
Tu Mu Kuo BRD	Director/Board Member	-	27/19/27
Yu Hao Yang BRD	Director/Board Member	-	30/15/30
Cheng Hui Hsiung CTO	Chief Tech/Sci/R&D Officer	-	01/14/01
Hsuan Che Liu BRD	Director/Board Member	-	08/17/08
Kai Min Zhu CEO	Chief Executive Officer	-	18/14/18
Yan Chen Huang BRD	Director/Board Member	-	01/19/01
Ming Chien Kao BRD	Director/Board Member	-	27/19/27
Tsung Chih Chiu BRD	Director/Board Member	-	27/19/27

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	71,165,750	70,870,500 ( 99.59 %)	0	99.59 %

Sinew Pharma, Inc.

C516, Building C No. 99, Lane 130, Section 1

115 71, Taipei

http://www.sinewpharma.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
SINEW PHARMA INC.	-18.32%	121M
MODERNA, INC.	+17.96%	44.96B
LONZA GROUP AG	+48.77%	41.85B
IQVIA HOLDINGS INC.	+1.17%	42.65B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research